Stock Report

All about this stock under one free report Last Updated: 29-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Insulet (PODD) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$133.11

up-down-arrow $-3.02 (-2.22%)

As on 28-Sep-2026 16:00EDT

Market cap

info icon

$9,441 Mln

Revenue (TTM)

info icon

$3,054 Mln

P/E Ratio

info icon

25.5

P/B Ratio

info icon

15

Div. Yield

info icon

0 %

Edit peer-selector-edit
Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Market cap ($ Mln)
 9,441 24,123 10,427 10,065 9,957
Revenue ($ Mln)
 3,054 17,664 4,140 2,589 3,145
Net Profit ($ Mln)
 375.30 1,114.00 413.58 222.40 535.46
Net Margin (%)
 12.29 6.31 9.99 8.59 17.03
RoE (%)
 25.55 9.93 9.99 3.04 11.46
Price to Earnings
 25.49 18.84 25.44 45.79 19.21
Price-To-Book
 15.03 1.83 2.49 1.43 2.12

Income Statement ($ Mln)

Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Operating Revenue arrow
3,053.50 17,664.00 4,139.53 2,589.30 3,144.90
Cost of Revenue arrow
883.10 9,551.00 1,387.59 1,245.50 989.14
Gross Profit arrow
1,939.90 8,058.00 2,756.90 1,343.60 1,981.10
Operating Expenses arrow
1,654.50 6,392.00 2,200.16 1,108.90 1,504.66
Operating Profit (EBIT) arrow
515.80 1,721.00 551.86 235.00 652.69
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
494.70 1,477.00 568.91 350.40 664.95
Provision for Tax arrow
119.30 364.00 155.33 128.00 129.49
Profit after Tax (Net Income) arrow
375.30 1,114.00 413.58 222.40 535.46
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 579.00 0.00 378.10 0.00

Liabilities ($ Mln)

Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Shareholder's Funds arrow
1,422.20 11,447.00 4,232.45 7,173.90 4,768.60
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Non-Current Liabilities arrow
998.70 7,802.00 276.53 2,116.80 240.31
Current Liabilities arrow
744.20 7,423.00 1,908.60 961.30 479.35
Total Liabilities arrow
3,190.40 26,944.00 6,233.69 10,576.50 5,302.76

Assets ($ Mln)

Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Non-Current Assets arrow
1,316.00 17,371.00 3,754.53 7,231.50 3,272.75
Current Assets arrow
1,849.10 9,330.00 2,663.05 3,020.50 2,215.51
Total Assets arrow
3,190.40 26,944.00 6,233.69 10,576.50 5,302.76
Total Debt* arrow
948.40 7,465.00 120.84 1,203.70 111.19
Net Current Assets arrow
1,104.90 1,907.00 754.45 2,059.20 1,736.17

Cashflow ($ Mln)

Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Cash From Operating Activities arrow
569.30 1,162.00 593.22 532.20 753.45
Cash Flow from Investing Activities arrow
-222.70 -737.00 -112.45 -189.70 -355.01
Cash from Financing Activities arrow
-595.30 107.00 -464.58 -283.20 -679.16
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
ROCE (%) arrow
9.50 4.64 10.09 8.98 11.44
ROE (%) arrow
25.55 9.93 9.99 3.04 11.46
ROA (%) arrow
8.97 3.29 5.00 2.02 9.43
EBIT Margin (%) arrow
13.73 10.30 15.19 -5.99 15.11
Net Margin (%) arrow
12.29 6.31 9.99 8.59 17.03
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Revenue Growth (%) arrow
29.41 -1.08 4.41 1.37 19.74
EBIT Growth (%) arrow
30.76 59.79 -3.03 -131.06 36.96
Net Profit Growth (%) arrow
58.96 587.65 -5.49 -30.32 50.14
EPS Growth (%) arrow
66.81 579.15 -2.80 -29.66 50.51
Book Value Growth (%) arrow
-1.05 8.94 9.63 2.19 9.65

Valuation Ratios

 Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Price / Earnings arrow
81.29 29.23 27.31 10.77 22.27
Price / Book Value arrow
13.26 2.39 2.77 1.10 2.62
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
38.36 11.92 13.35 6.54 15.81
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Debt to Equity arrow
0.65 0.55 0.00 0.11 0.00
Short term debt to equity ratio arrow
0.01 0.10 0.01 0.06 0.00
Current Ratio arrow
2.48 1.26 1.40 3.14 4.62
Quick Ratio arrow
1.83 0.82 1.28 2.33 2.93
Interest Coverage arrow
8.80 5.06 364.75 8.18 97.52

Operating Efficiency Ratios

 Insulet (PODD) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Debtors to sales (%) arrow
19.28 20.36 27.74 17.06 23.51
Asset Turnover arrow
0.73 0.52 0.50 0.24 0.55
Receivable days arrow
59.51 73.75 99.00 65.39 82.15
Inventory Days arrow
209.92 113.36 68.68 221.09 270.47
Payable days arrow
22.54 70.18 32.89 37.02 33.17
Cash Conversion Cycle arrow
246.89 116.92 134.79 249.46 319.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...